The expression of FOXP3 and IL-10 mRNA was obviously decreased in the tumor-bearing mice of the treatment group, while the secretion of IL-12 was increased and the contents of IL-10 and TGF-β were decreased. This evidence concerns the gene IL10 and neoplasm.